Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Marijuana use may be linked to lower TSH levels, but the exact cause is unclear.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride works better for hair loss in patients 26 or younger.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.